Initiative for Fast-Track Review and Publication of Research and Data Relevant to COVID-19 Response

INITIATIVE FOR FAST-TRACK REVIEW AND PUBLICATION OF RESEARCH AND DATA RELEVANT TO COVID-19 RESPONSE

IEEE OJEMB has created a fast-track for rapid review and publication of research and data that may help in the fight against COVID-19....

Drugs to Treat Novel Coronavirus Part 2: Rx for Restraint

DRUGS TO TREAT NOVEL CORONAVIRUS PART 2: RX FOR RESTRAINT

It's impossible to keep up with entries at ClinicalTrials.gov that include the search term “COVID-19.” Last week when I posted Can...

 
 
 
New Technique Looks for Dark Matter Traces in Dark Places

NEW TECHNIQUE LOOKS FOR DARK MATTER TRACES IN DARK PLACES

In this composite image, theorized particles of decaying dark matter should produce a spherical halo of X-ray emission - represented...

SCIENTISTS CAN NOW EDIT MULTIPLE GENOME FRAGMENTS AT A TIME

Scientists have developed CHyMErA, a new CRISPR-based tool for more versatile genome editing applications to help shed light on how...

 
 
 

IPSEN SCRAPS PIVOTAL TRIAL AS PARTIAL CLINICAL HOLD DRAGS ON

Ipsen has terminated a pivotal trial of its troubled rare disease drug palovarotene in response to the ongoing clinical hold. The action...

COVID-19 PROMPTS PFIZER TO STOP ENROLLMENT IN MOST STUDIES

Pfizer has paused enrollment in many new and ongoing clinical trials in response to the COVID-19 pandemic, Reuters reports. The action...

 
 
 

CRISP: ACCURATE STRUCTURE PREDICTION OF DISULFIDE-RICH PEPTIDES WITH CYSTINE-SPECIFIC SEQUENCE ALIGNMENT AND MACHINE LEARNING

AbstractMotivationHigh-throughput sequencing discovers many naturally occurring disulfide-rich peptides or cystine-rich peptides with...

DELMAR PHARMACEUTICALS RECEIVES NASDAQ BID PRICE EXTENSION

SAN DIEGO, March 26, 2020 /PRNewswire/ - DelMar Pharmaceuticals, Inc. , a biopharmaceutical company focused on the development of new...

 
 
 

CANCER BIOTECH VIRACTA NABS NORDIC NANOVECTOR EXEC AS CMO

Lisa Rojkjaer, M.D., has been named Viracta's new chief medical officer as Nordic Nanovector adds interim replacement.

OBALON ENGAGES CANACCORD GENUITY TO EXPLORE FINANCIAL AND STRATEGIC ALTERNATIVES

SAN DIEGO, March 25, 2020 - Obalon Therapeutics, Inc. , a vertically integrated weight loss solutions company commercializing the first...

 
 
 

PSCRIDB: A DATABASE OF REGULATORY INTERACTIONS AND NETWORKS OF PLURIPOTENT STEM CELL LINES

Abstract Pluripotency in stem cells is regulated by a complex network between the transcription factors, signaling molecules, mRNAs,...

SCIENTIST - ILLUMINA - SAN DIEGO, CA

Strong data analysis skills, ability to interpret and draw conclusions from vast amounts of data. Knowledge of technology development...

 
 
 

LNCRNA XIST KNOCKDOWN AMELIORATES OXIDATIVE LOW-DENSITY LIPOPROTEIN-INDUCED ENDOTHELIAL CELLS INJURY BY TARGETING MIR-204-5P/TLR4

Abstract Oxidative low-density lipoprotein -induced endothelial cell injury is a key contributor to atherosclerosis development. However,...

Sequencing 101: The Evolution of DNA Sequencing Tools

SEQUENCING 101: THE EVOLUTION OF DNA SEQUENCING TOOLS

Welcome to the Sequencing 101 blog series - where we will provide introductions to sequencing technology, genomics, and much more! If...

 
 
 

VIRACTA ANNOUNCES APPOINTMENT OF LISA ROJKJAER, MD, AS CHIEF MEDICAL OFFICER

SAN DIEGO, March 25, 2020 /PRNewswire/ - Viracta Therapeutics, Inc. , a precision oncology company targeting virus-associated malignancies,...

 
 
 

HOW TRANS FATS ASSIST CELL DEATH

Researchers have uncovered a molecular link between some trans fats and a variety of disorders, including cardiovascular and neurodegenerative...

Kallyope Gains $112M to Move “Gut-Brain Axis” Programs to the Clinic

KALLYOPE GAINS $112M TO MOVE “GUT-BRAIN AXIS” PROGRAMS TO THE CLINIC

Kallyope, one of New York's best funded biotechs, has secured more than $100 million to move two of its programs into the clinic-including...

 
 
 
CytomX Lands $80M to Kick Off Cancer Drug R&D Pact With Astellas

CYTOMX LANDS $80M TO KICK OFF CANCER DRUG R&D PACT WITH ASTELLAS

CytomX Therapeutics is teaming up with Astellas Pharma in a research and development alliance focused on developing new cancer immunotherapies...

Palforzia Peanut Allergy Immunotherapy: Aimmune CEO on REMS, Manufacturing

PALFORZIA PEANUT ALLERGY IMMUNOTHERAPY: AIMMUNE CEO ON REMS, MANUFACTURING

Aimmune Therapeutics Inc. is navigating a host of new challenges as it launches Palforzia, the first peanut allergy immunotherapy to...